Analyst Ratings for ADMA Biologics (ADMA) [Buys]
ADMA Rating Summary
ADMA Price Target Summary
- Highest: $10.00 (Mizuho)
- Lowest: $6.00 (Raymond James)
- Average: $7.83
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.83 (+28.4%)
* Over Last 12-Mos
Rating Score: 9 / 10
Percentile Rank: 90%
Avg. $ Target:
$7.83 (+28.4%)
* Over Last 12-Mos
Rating Score: 9 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/19/2023 | Raymond James » Updated 8/10/2023 |
Gary Nachman | New Coverage | Strong Buy (N/A) |
6.00 (5.00) |
3.57 (6.10) |
70.87% | Details |
| 10/13/2022 | Mizuho » Updated 3/1/2024 |
Anthony Petrone | New Coverage | Buy (N/A) |
10.00 (9.00) |
2.49 (6.10) |
144.98% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
